新京报记者调查发现，医保基金面临多种套现乱象[1]。其中眼镜店与药店串通刷医保、连锁药店将日用品包装成医疗器械进行虚假刷医保、中介利用"亲情账户"为他人套现等行为普遍存在[1]。医保套现中介的返点比例从50%到60%不等[1]，参保人在此过程中损失严重。以套现参保人张伟为例，其刷医保760元购买片仔癀，最终被中介以220元价格收购，实际损失540元[1]。
针对这些违规行为，国家医保部门今年上半年开展了专项行动[1]。飞行检查已基本覆盖全国所有省份，共检查227个地市的2926家定点医药机构，查处涉嫌违法违规金额11.6亿元[1]。同时，专项行动对320种重点监测的易倒卖回流药品取得明显成效，其医保支出同比下降20%[1]。为进一步规范，国家医保局和财政部于今年5月发布通知，决定建立定点零售药店职工医保个人账户支付白名单制度[1]。
Investigators have uncovered widespread schemes to illegally extract money from China's medical insurance system, including collusion between optical shops and pharmacies to process fraudulent claims, and intermediaries exploiting family account access to convert benefits into cash.[1]
The National Medical Insurance Administration launched a crackdown in the first half of this year, targeting the most commonly diverted and resold medications covered under the system. Among 320 high-risk drugs monitored, insurance payments dropped 20 percent compared to the same period last year, with authorities uncovering violations totaling 1.16 billion yuan across the country.[1] National inspections have covered all provinces, examining 2,926 designated medical institutions across 227 cities and identifying 11.6 billion yuan in alleged illegal activities.[1]
The scheme operates through multiple channels: chain pharmacies repackage daily consumer goods as medical devices to process insurance claims, while intermediaries offering cash-out services take commissions ranging from 50 to 60 percent of the benefit amount.[1] In one documented case, an insured individual named Zhang Wei purchased 760 yuan worth of Pien Tze Huang through a fraudulent claim, only to have an intermediary purchase it back for 220 yuan—a loss of 540 yuan to the fund.[1] In response, the National Medical Insurance Administration and Ministry of Finance announced in May that designated retail pharmacies would implement a whitelist system restricting which items can be purchased using the employee medical savings account.[1]
